Literature DB >> 24424196

Diagnostic features of the autoimmune retinopathies.

T Braithwaite1, G E Holder2, R W J Lee3, G T Plant4, A Tufail5.   

Abstract

The term autoimmune retinopathy encompasses a spectrum of rare autoimmune diseases that affect retinal function, often but not exclusively at the level of the photoreceptor. They typically present with painless visual loss, which may be accompanied by normal fundus examination. Some are progressive, often rapidly. They present a diagnostic challenge because there are no standardised clinical or laboratory based diagnostic criteria. Included within the spectrum are cancer-associated retinopathy, melanoma-associated retinopathy and presumed non-paraneoplastic autoimmune retinopathy. Differentiation from other retinopathies can be challenging, with overlap in symptoms, signs, and investigation findings, and an absence of pathognomonic features. However, technological developments in ophthalmic imaging and serological investigation over the past decade are adding novel dimensions to the investigation and classification of patients with these rare diseases. This review addresses the clinical, imaging, and serological features of the autoimmune retinopathies, and discusses the relative strengths and limitations of candidate diagnostic features.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24424196     DOI: 10.1016/j.autrev.2014.01.039

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  10 in total

Review 1.  The enigma of autoimmune retinopathy.

Authors:  Farzin Forooghian; Sijia Cao; Jing Cui; Joanne A Matsubara
Journal:  Int Ophthalmol Clin       Date:  2015

2.  Unilateral cancer-associated retinopathy: diagnosis, serology and treatment.

Authors:  Dimitri Roels; Shinji Ueno; Cornelia D Talianu; Dafina Draganova; Mineo Kondo; Bart P Leroy
Journal:  Doc Ophthalmol       Date:  2017-08-16       Impact factor: 2.379

Review 3.  Autoimmunity in 2014.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

4.  Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach.

Authors:  Austin R Fox; Lynn K Gordon; John R Heckenlively; Janet L Davis; Debra A Goldstein; Careen Y Lowder; Robert B Nussenblatt; Nicholas J Butler; Monica Dalal; Thiran Jayasundera; Wendy M Smith; Richard W Lee; Grazyna Adamus; Chi-Chao Chan; John J Hooks; Catherine W Morgans; Barbara Detrick; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2016-05-20       Impact factor: 5.258

Review 5.  Autoimmune Retinopathy: Current Concepts and Practices (An American Ophthalmological Society Thesis).

Authors:  H Nida Sen; Landon Grange; Marib Akanda; Austin Fox
Journal:  Trans Am Ophthalmol Soc       Date:  2018-03-08

6.  Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy.

Authors:  Josianne C Ten Berge; Joost van Rosmalen; Jacolien Vermeer; Cecilia Hellström; Cecilia Lindskog; Peter Nilsson; Ulrika Qundos; Aniki Rothova; Marco W J Schreurs
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

Review 7.  An update on autoimmune retinopathy.

Authors:  Parthopratim Dutta Majumder; Alessandro Marchese; Francesco Pichi; Itika Garg; Aniruddha Agarwal
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

8.  Complete Visual Recovery From Severe Outer Retinitis After Tonsillitis.

Authors:  Rumi Kawashima; Kenji Matsushita; Noriyasu Hashida; Kazuki Kuniyoshi; Takashi Fujikado; Kohji Nishida
Journal:  J Neuroophthalmol       Date:  2021-12-01       Impact factor: 4.415

Review 9.  Autoimmunity in visual loss.

Authors:  Axel Petzold; Sui Wong; Gordon T Plant
Journal:  Handb Clin Neurol       Date:  2016

Review 10.  Negative electroretinograms: genetic and acquired causes, diagnostic approaches and physiological insights.

Authors:  Xiaofan Jiang; Omar A Mahroo
Journal:  Eye (Lond)       Date:  2021-06-14       Impact factor: 3.775

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.